Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis
Medicina Clínica
· Elsevier
Аннотация
Publication date: Available online 30 October 2026 Source: Medicina Clínica Author(s): Ángela García-Oro, Amparo Puerta-García, Javier Solera
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Медицина (общая)»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis. // Medicina Clínica. – URL: https://www.sciencedirect.com/science/article/pii/S0025775326003349?dgcid=rss_sd_all
Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis. Medicina Clínica. https://www.sciencedirect.com/science/article/pii/S0025775326003349?dgcid=rss_sd_all
“Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis.” Medicina Clínica.
@article{article117337,
title = {Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis},
journal = {Medicina Clínica},
url = {https://www.sciencedirect.com/science/article/pii/S0025775326003349?dgcid=rss_sd_all}
}